News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Patent News
Genticel Granted Five New Patents In The Us And Asia During First Half Of 2014 7/24/2014
MYOS (MYOS) Receives Notice Of Allowance Of U.S. Patent Application For Proprietary Manufacturing Methods Of Fortetropin 7/24/2014
Particle Sciences And Eyeon Therapeutics Receive Patent On Novel Dry Eye Technology 7/22/2014
U.S. Patent Office Grants McCord Research Endothelial Cell Treatment Patent 7/22/2014
Alnylam Pharmaceuticals (ALNY) Receives Notice Of Allowance From United States Patent And Trademark Office (USPTO) For New Patent Broadly Covering Conjugate-Based Delivery Of RNA Therapeutics 7/22/2014
Opko Health, Inc. Granted Patent From U.S. Patent & Trademark Office For RAYALDEE 7/22/2014
Drawbridge Pharmaceuticals Extends Phaxan™ Patent Portfolio With Divisional Patents Granted For Other Neuroactive Steroids 7/22/2014
Hepatitis C Spurs Unusual Patent Wars Among Big Drug Makers 7/21/2014
Integral Molecular, Inc. Announces Patent Allowance For Dengue Research Technology 7/18/2014
BMC To Actively Defend Against Curative In Patent Fight 7/18/2014
Agile Therapeutics, Inc. Announces Allowance Of Additional Patent Claims For Skinfusion® 7/18/2014
Columbia Laboratories, Inc. (CBRX) Expands Its Intellectual Property Portfolio Following Receipt Of U.S. Patent 7/17/2014
Prima Biomed (PRR.AX) Receives U.S. Patent Grant For CVac 7/16/2014
Arena Pharmaceuticals, Inc. (ARNA) Issued Patent For APD371 By United States Patent And Trademark Office 7/16/2014
InSite Vision (ISV) Announces The Issuance Of Broad U.S. Patent Covering Bromfenac Formulations In Durasite® 7/16/2014
Lipocine Inc. (LPCN) Announces Issuance Of U.S. Patent For LPCN 1021 7/16/2014
C4X Discovery Patent Granted In Japan 7/15/2014
Kraig Biocraft Laboratories, Inc. Announces U.S. Patent And Trademark Office Has Registered The Company's Monster Silk® Trademark 7/15/2014
BioTime (BTX) Announces Issuance Of 14 Patents In The Fields Of Regenerative Medicine, And Cancer Diagnosis And Therapy 7/14/2014
Actavis (ACT) Confirms Generic Diclegis® Patent Challenge 7/14/2014
Zogenix, Inc. (ZGNX) Announces New Patent Valid Through 2032 For DosePro® Needle-Free Delivery System 7/14/2014
Transplant Genomics Inc. Announces Exclusive License To Patent Rights Co-Owned By The Scripps Research Institute And Northwestern University 7/14/2014
Microbix Biosystems Inc. (MBXBF) Sues Novartis AG (NVS) For Infringement Of Its VIRUSMAX® Patent In Europe 7/10/2014
Rosetta Genomics Ltd. (ROSG) Receives Notice Of Allowance For U.S. Patent For The Treatment Of Ovarian Cancer 7/10/2014
Pharmalink AB's Core Patents For Nefecon® Treatment For Renal Disease Granted In United States, Europe, China And Hong Kong 7/10/2014
Cellular Dynamics International Awarded Patents Covering Derivation Of Pluripotent Stem Cells From Fresh Or Banked Human Blood Samples 7/10/2014
Alkermes plc (ALKS) Announces Notices of Allowance For U.S. Patents For Four CNS Pipeline Candidates 7/9/2014
Palatin Technologies (PTN) Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides 7/9/2014
Actavis (ACT) Confirms Generic Ampyra® Patent Challenge 7/8/2014
Aegis Therapeutics, LLC Awarded US Patent For Stable "Shirt-Pocket" Insulin Suitable For Metered Nasal Spray Or Injection 7/8/2014
Access Pharmaceuticals (ACCP) Awarded Hong Kong Patent For MuGard 7/8/2014
Sirnaomics Strengthens Its IP Position For Advancing The Company's Novel siRNA Therapeutics Programs 7/8/2014
ZS Pharma (ZSPH) Announces Allowance Of Two U.S. Patent Applications For ZS-9 7/8/2014
Q Therapeutics, Inc. Announces First U.S. Patent Relating To Fifth Patent Family On Neural Cells 7/7/2014
Seres Health Announces Allowance For Key Patent On The Use Of Synergistic Bacterial Compositions 7/7/2014
22nd Century Group, Inc. Announces Allowance of U.S. Patent For Regulating Nicotine in Tobacco Using Transcription Factor Gene 7/3/2014
Collegium Pharmaceutical, Inc. Announces Issuance Of U.S. Patent Covering Oxycodone DETERx®, An Abuse-Deterrent, Extended-Release Opioid Product 7/2/2014
OncoMed Pharmaceuticals, Inc. (OMED) Granted Broad FZD-Fc Composition-Of-Matter And Use Patent In U.S. 7/2/2014
Valensa Is Granted New Patents For "Worry Free" Chia-Based Ingredients 7/1/2014
Galena Biopharma  (GALE) Receives Notice Of Allowance Of Broad U.S. Patent For Neuvax™ (Nelipepimut-S) 7/1/2014
Premier Biomedical Announces Important Patent Award For A Potential Multi-Billion Dollar Drug For The Treatment Of Fibromyalgia And Neuralgia 6/30/2014
Actavis (ACT) Confirms Generic Zubsolv® Patent Challenge 6/30/2014
Mati Therapeutics Expands Patent Portfolio 6/30/2014
Opko Health, Inc. Granted Patent from European Patent Office For Lagova™ 6/27/2014
Orexo AB (ORXOF) Commences Patent Infringement Litigation Against Actavis (ACT) 6/27/2014
Shire Pharmaceuticals (SHPG) Release: Vyvanse® Patents Found To Be Infringed And Valid By U.S. District Court 6/25/2014
Regulus Therapeutics, Inc. Announces Patent Grant From U.S. Patent Office In Sarnow Patent Estate On Microrna Therapeutics For The Treatment Of HCV 6/25/2014
BioInvent (BOVNF) Granted U.S. Patent For BI-505 And Apoptosis-Inducing ICAM-1 Antibodies 6/24/2014
Ryogen LLC Is Awarded Patent For Polynucleotides Related To Tumor-Suppressing Subtransferable Candidate 4 6/24/2014
Advaxis, Inc. Receives Notice Of Allowance From U.S. Patent Office For Two Patent Applications With Multiple Claims Covering Its Cancer Immunotherapy ADXS-Cher2 6/23/2014
Perrigo Company (PRGO) Announces Settlement In Proair® HFA Patent Case 6/20/2014
TriLink BioTechnologies Awarded Patents For Novel Ligation Technology In US, Europe And New Zealand 6/19/2014
Pluristem Therapeutics (PSTI) Granted Patent In Russia For Treatment Of Inflammatory Bowel Disease Using Placenta-Derived Cells 6/19/2014
Actavis (ACT) Confirms District Court Ruling In Generic Exelon® Patch Patent Suit 6/19/2014
Drawbridge Pharmaceuticals Granted New Anaesthesia Patent For Phaxan™ In China 6/18/2014
Forest Laboratories, Inc. (FRX) Obtains Six Months U.S. Pediatric Exclusivity for NAMENDA® and NAMENDA XR® 6/18/2014
Patrys Limited (PAB.AX) Granted Third U.S. Patent For Lead Clinical Product PAT-SM6 6/18/2014
ProLynx Issues U.S. Patent Covering Controlled Release Drug Conjugates 6/18/2014
Keryx Biopharmaceuticals (KERX) Announces Issuance Of Two U.S. Patents For Zerenex(TM) Covering Orally Administrable Forms Of Ferric Citrate 6/18/2014
Essentialis Announces The Grant Of Its First Japanese Patent Which Provides Extensive Protection To DCCR In The Treatment Of Prader-Willi Syndrome 6/17/2014
ArmaGen Technologies, Inc. Receives Notice Of Allowance For U.S. Patent Covering Novel Investigational Therapy For Hunter Syndrome 6/17/2014
Teva Pharmaceutical Industries Limited (TEVA) Reaches Settlements In NUVIGIL® Patent Case 6/17/2014
VistaGen Therapeutics, Inc. Receives Notice Of Allowance For Canadian Patent Expanding Stem Cell Technology Platform 6/16/2014
Arrowhead Research Corporation (ARWR) Issues A Statement On Intellectual Property Protection For ARC-520 6/16/2014
Pluristem Therapeutics (PSTI) Receives Patent In India For Cell Therapy Production Methods And Compositions 6/16/2014
The United States Patent Office Grants Neol Biosolutions The Patent For The Technology Microbioil-1® 6/12/2014
Spherix (SPEX) Commences Litigation Against Verizon For Patent Infringement 6/12/2014
Zealand Pharma  (ZEAL.CO)’s GLP-2 Analogue European Patent Rights Upheld By The European Patent Office Opposition Division 6/12/2014
Alnylam Pharmaceuticals (ALNY) Announces United States Patent And Trademark Office (USPTO) Issues Patent Covering Rnai Therapeutics For The Treatment Of Hepatitis B Virus (HBV) Infection 6/12/2014
Milan District Court Confirms The Validity Of Alfa Wasserman's Rifaximin-Alpha Patents 6/12/2014
BioLineRx Ltd. Receives Notice Of Allowance For US Patent Covering Novel Treatment For Celiac Disease 6/11/2014
Catabasis Pharmaceuticals, Inc. Announces Issuance Of Three New US Patents For CAT-1000 Series 6/11/2014
iBio, Inc. (IBIO) Expands IP Protection Of Biotherapeutic Product For Treatment Of Fibrosis 6/10/2014
Titan Pharmaceuticals (TTP) Receives Notice Of Allowance For Patent Of Implantable Polymeric Device For Sustained Release Of Dopamine Agonists 6/10/2014
Palatin Technologies (PTN) Announces Notification Of Patent Allowance On Next Generation Melanocortin Receptor-Specific Peptides 6/10/2014
Stemedica Cell Technologies, Inc. Earns U.S. Patent For Cellular Scaffold Enhanced By Stem Cell Factors 6/10/2014
PharmAthene, Inc. (PIP) Granted U.S. Patent For Recombinant Bioscavenger 6/9/2014
Galmed Pharmaceuticals Announces The Filing Of A Provisional Patent Application For The Use Of Aramchol For The Treatment Of Lipodystrophy 6/9/2014
Xenetic Biosciences Strengthens Technology Patent Portfolio 6/9/2014
AMAG Pharmaceuticals, Inc. (AMAG) Announces Patent Term Extension For Ferumoxytol In The U.S. 6/6/2014
Marina Biotech, Inc. (MRNA) Receives Decision To Grant Japanese Patent For Its SMARTICLES Nucleic Acid Delivery Technology 6/6/2014
Enzo Biochem (ENZ) Awarded U.S. Patent On More Efficient Vector For Use In Gene Therapy 6/6/2014
Scancell: DNA ImmunoBody Patent Granted In United States 6/5/2014
Qu Biologics Granted Broad New Zealand Patent Involving Immunotherapies Derived From Viruses For Treating A Range Of Cancers 6/5/2014
iBio, Inc. (IBIO) European Patent On iBioModulator Technology Emerges From Opposition Period 6/5/2014
Suven Life Sciences Ltd Secures One Product Patent In U.S.A. 6/4/2014
Anavex Life Sciences Corp. (AVXL.OB) Awarded New U.S. Patent 6/4/2014
ERYtech Pharma Strengthens Its Intellectual Property Portfolio 6/2/2014
Mylan Inc. (MYL) Settles Patent Litigation Related To Celebrex® Capsules 6/2/2014
Actavis (ACT) Announces Nuvigil® Patent Challenge Settlement 6/2/2014
Iroko Pharmaceuticals Granted Key Patent For TIVORBEX™ 5/28/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Favorable European Patent Office Ruling In COPAXONE® Patent Proceeding 5/28/2014
Galectin Therapeutics Receives U.S. Patent For GR-MD-02 In Diabetic Nephropathy, A Progressive Kidney Disease 5/28/2014
Actavis (ACT) Confirms Generic Onglyza® Patent Challenge 5/28/2014
Prima Biomed (PRR.AX)'s CVac Patent Application Receives U.S. Notice Of Allowance 5/27/2014
Hemispherx Biopharma (HEB) Receives New U.S. Composition Of Matter Patent Covering Ampligen® Formulations 5/27/2014
Batu Biologics Files Patent Covering Its Proprietary Cancer Vaccine Targeting The Tumor Endothelium: Vallovax 5/27/2014
Transposagen Biopharmaceuticals, Inc. Issued Key U.S. Patent Covering Rat Models Of Cancer 5/23/2014
Suven Life Sciences Ltd Product Patents In Australia, South Korea And China 5/19/2014
Innovus Pharma Announces The Issuance Of A New Canadian Patent For Its Zestra® Product 5/19/2014
Neos Therapeutics Announces Issuance Of New Patent Covering Composition Of Matter For Company’s Novel ADHD Products 5/15/2014
BioLight Announces U.S. Patent Approval For Its Formulation Of Latanoprost In Its Proprietary Controlled Release Insert For The Treatment Of Glaucoma 5/14/2014
Appethyl's U.S. Patent, "Use Of Plant Cell Membrane For The Treatment Of Obesity" Issued To Greenleaf Medical AB 5/13/2014
Sunshine Biopharma, Inc. Announces Issuance Of Notice Of Allowance For The Patent Application Covering Adva-27a Anticancer Compound In Canada 5/12/2014
Batu Biologics Files Patent Covering New Use Of Approved Drug For Decreasing Cancer Immunotherapy Toxicity 5/12/2014
AtheroNova Inc. (AHRO.OB) Receives Notice Of Issuance Of Its 2nd US Patent 8,697,633 5/8/2014
Synthetic Biologics, Inc. (SYN) Announces Recent International Patents That Bolster Its C. Difficile Program 5/8/2014
Can-Fite BioPharma (CFBI) Receives Patent In European Union For Treatment Of Liver Function Following Surgery 5/8/2014
Pivotal Therapeutics Inc. Announces Issuance Of U.S. Patent 8,715,648 For Its Unique 6:1 EPA:DHA Formulation 5/8/2014
Omni Bio Pharmaceutical Announces Grant Of New Use Patent In Europe 5/8/2014
Discovery Laboratories (DSCO) Expands Exclusivity Portfolio With Three New U.S. Patents 5/7/2014
Cyclacel Pharmaceuticals, Inc. (CYCC) Release: New Japanese Patents Issued Covering Sapacitabine Pharmaceutical Formulations And Combination Treatments 5/5/2014
Alcobra (ADHD) Issued New US Patent Covering Metadoxine Use For Cognitive Disorders 5/1/2014
ADial Pharmaceuticals Announces Issuance Of First U.S. Patent 5/1/2014
AVANIR Pharmaceuticals (AVNR) Prevails In NUEDEXTA Patent Trial Resulting In Exclusivity Through 2026 4/30/2014
KemPharm, Inc. Receives Notice Of Allowance For Novel Prodrug Of Hydromorphone 4/30/2014
BioAtla Receives Broad Patent Covering Conditionally Active Biologics 4/30/2014
Curis, Inc. (CRIS) Announces U.S. Patent Issuance Covering CUDC-907 Composition-Of-Matter 4/30/2014
Braasch Biotech Continues To Build Patent Portfolio With Acceptances In The European Union, Russia And Israel 4/28/2014
Premier Biomedical Receives Notice Of Allowance On Broad Base Patent 4/24/2014
iBio, Inc. (IBIO) Receives Patent Allowance In China For Fusion Protein Compositions And Technology 4/24/2014
Actavis (ACT) Announces Celebrex® Patent Challenge Settlement 4/24/2014
U.S. District Court Finds In Favor Of Azbil BioVigilant, Inc. In Patent Litigation Dispute 4/24/2014
Epizyme (EPZM) Announces Notice Of Allowance For U.S. Patent Application Covering Methods Of Treatment For Cancers With EZH2 Inhibitors 4/24/2014
BaroFold, Inc. Awarded Patent For Using High Pressure To Improve The Safety Profile Of Biologic Drugs 4/23/2014
ProLynx Issues U.S. Patent Covering Controlled Drug Release From Dendrimers 4/23/2014
TWi Pharmaceuticals, Inc. Announces Settlement Of Lidoderm® Patent Litigation 4/23/2014
VistaGen Therapeutics, Inc. Receives Notice Of Allowance For U.S. Patent Expanding Stem Cell Technology Platform For Drug Rescue And Regenerative Medicine 4/23/2014
Foamix Announces The Issuance Of Five Additional U.S. Patents 4/21/2014
Skystar Bio-Pharmaceutical (CGPN) Provides Update To Its Patent Portfolio 4/17/2014
Teva Pharmaceutical Industries Limited (TEVA) Settles Patent Litigation With Pfizer Inc. (PFE) On Celebrex® 4/17/2014
IntelGenx Corp. Announces Receipt Of An Additional U.S. Patent Allowance Related To Proprietary Technology 4/16/2014
Xeris Pharmaceuticals Receives U.S. Patent For Its Novel, Stable Non-Aqueous Glucagon Formulations 4/16/2014
Antares Pharma, Inc. (ATRS) Announces Additional Patent Coverage For OTREXUP 4/16/2014
Drawbridge Pharmaceuticals Announces Successful Clinical Trial Results For Phaxan™ And Grant Of U.S. Patent 4/16/2014
Alzheon Announces Notice Of Allowance For U.S. Patent For Its Lead Drug Candidate ALZ-801 In Clinical Development For Alzheimer’s Disease 4/15/2014
Depomed, Inc. (DEPO) Announces Settlements With Two Gralise® ANDA Filers 4/14/2014
Japan Patent Office Issues Advaxis, Inc. A Notice Of Allowance For Two Patent Applications Covering Its Cancer Immunotherapy Platform Technology 4/14/2014
Suven Life Sciences Ltd Secures (2) Product Patents For Their NCEs In Canada And Hong Kong 4/10/2014
Horizon Pharma Announces the U.S. Patent and Trademark Office Issued An Additional Notice Of Allowance With Claims Covering RAYOS® (Prednisone) Delayed-Release Tablets 4/10/2014
BrainStorm Cell Therapeutics Inc. Granted Additional US Patent For Its Autologous Stem Cell Technology 4/10/2014
Oramed Pharmaceuticals Inc. (ORMP) Granted Patent In Hong Kong For Oral Administration Of Insulin 4/10/2014
American CryoStem Corporation And Rutgers University File Joint Patent On Adipose-Derived Stem Cell Platform Technology 4/10/2014
Critical Pharmaceuticals Limited Receives Notice Of Allowance From US Patent And Trademark Office For Intranasal Growth Hormone And Parathyroid Hormone Products 4/8/2014
Epizyme (EPZM) Granted Patent Covering Diagnosis And Treatment Of Cancers Associated With EZH2 Mutation 4/8/2014
USPTO Grants A New Inhaler Patent To Hovione 4/7/2014
Alnylam Pharmaceuticals (ALNY)’s McSwiggen Patent Upheld in European Opposition Proceedings 4/7/2014
United States PTO Rejects Teva's '808 Patent Reissue Application On Copaxone® For The Second Time 4/4/2014
AnaptysBio, Inc. Announces Issuance Of United States Patent Covering Proprietary Antibody Humanization Technology 4/3/2014
IntelliCell BioSciences (SVFC) Has Received Its Hong Kong Patent Application Notice For ULTRASONIC CAVITATION 4/2/2014
Mersana Therapeutics, Inc. Awarded Patent With Broad Coverage For Fleximer-ADC Platform Technology 4/2/2014
GlaxoSmithKline (GSK)'s ViiV Healthcare Unit Adds New HIV Drug To AIDS Patent Pool 4/2/2014
The Medicines Company (MDCO) Release: Update On Angiomax® (Bivalirudin) Patent Litigation 4/1/2014
Eagle Pharmaceuticals (EGRX)’ Exclusive Licensor Granted U.S. Patent For Dantrolene In The Treatment Of Heat Stroke 4/1/2014
Enzymotec Provides Update On Patent Litigation With Neptune Technologies & Bioressources Inc. 4/1/2014
Advaxis, Inc. Receives Notice Of Allowance From U.S. Patent And Trademark Office For Three Patent Applications With Multiple Claims Covering Its Cancer Immunotherapy Platform Technology 4/1/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces U.S. Supreme Court Will Hear Its Appeal on COPAXONE® Patent 3/31/2014
Integral Molecular, Inc. Announces Patent Protecting The Use Of Lipoparticles For Antibody Discovery 3/31/2014
iBio, Inc. (IBIO) Receives Patent Allowances For Pandemic Influenza Therapeutics 3/27/2014
ProLynx Issues U.S. Patent Covering Beta-Eliminative Linkers 3/26/2014
Suven Life Sciences Ltd Secures (2) Product Patents For Their NCEs In U.S.A. 3/26/2014
Iroko Pharmaceuticals Announces Key Patent Grant For ZORVOLEX™ 3/25/2014
BrainStorm Cell Therapeutics Inc. Granted Key US Patent For Its Autologous Stem Cell Technology 3/24/2014
Moberg Pharma AB (Formerly known as Moberg Derma) Launches New Patent Pending Formulation Of Kerasal Nail In The U.S. 3/24/2014
Merck & Co., Inc. (MRK) HIV Drug Strategy Seen Shielding Patent 3/21/2014
MultiCell Technologies Inc. (MCET.OB) Files U.S. And International Patent Applications For The Treatment Of Liver Cancer 3/21/2014
TapImmune Inc. (TPIV) Is Pleased To Announce The Filing Of New Intellectual Property Surrounding Its Novel And Proprietary Platform Expression System Polystart™ 3/20/2014
Actavis (ACT) Announces Daytrana® Patent Challenge Settlement 3/20/2014
Collegium Pharmaceutical, Inc. Announces Allowance Of New Claims Covering DETERx®, An Abuse-Deterrent, Extended-Release, Technology Platform 3/19/2014
Advaxis, Inc. Receives Patent In Japan For ADXS-HPV For The Treatment Of Cervical Cancer 3/18/2014
Idenix Pharmaceuticals, Inc. (IDIX) Files Patent Infringement Lawsuits Against Gilead Sciences, Inc. (GILD) In Europe 3/14/2014
BioLineRx Ltd. Announces Issuance Of United States Patent Covering Use Of BL-8040 In Immunotherapy 3/14/2014
Pfizer Inc. (PFE) Faces Earlier Celebrex Competition After Ruling, Vows To Appeal 3/13/2014
TNI BioTech Granted Additional Patent For Methods For Inducing Sustained Immune Response Of T-Cells 3/12/2014
XBiotech USA, Inc. Issued Patent For Antibody Therapy To Treat Chronic Sterile Inflammatory Diseases 3/12/2014
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Third US Patent Protecting Trokendi XR™ 3/12/2014
Elite Pharmaceuticals, Inc. (ELI) Expands Abuse Deterrent Technology Patent Portfolio Internationally 3/10/2014
Ensysce Biosciences Inc. Receives Notice Of Allowance For U.S. Patent For Delivery Of siRNA 3/7/2014
Generex Biotechnology Corporation (GNBT) Subsidiary Antigen Express Receives Patents For Vaccines Targeting HPV Induced Cancers And Influenza 3/5/2014
RXi Pharmaceuticals (RXII) Granted Key Patent Related To Self-Delivering Technology For The Treatment Of Fibrotic Disorders 3/5/2014
Braasch Biotech Bolsters Intellectual Property With Patent Acceptances In Australia And Japan 3/4/2014
Synageva BioPharma (GEVA) Issued U.S. Patent For Treatment Of LAL Deficiency 3/4/2014
Fibrotech Is Granted U.S. And Canadian Patents For Its Anti-Fibrotic Compounds 3/3/2014
Settlement Between BioPorto And Phadia AB In Patent Case 3/3/2014
Actavis (ACT) Confirms Generic Colcrys® Patent Challenge 2/28/2014
Galena Biopharma  (GALE) Bolsters Neuvax™ (Nelipepimut-S) Intellectual Property With Patent Acceptance In Australia 2/28/2014
Immunomedics, Inc. (IMMU) Extends Patent Life On Therapeutic Antibodies 2/27/2014
Meditope Biosciences Announces Issuance of New Patent 2/26/2014
Theranostics Health Announces Issuance Of U.S. Patent 8,628,931 B2: mTOR Pathway Theranostic 2/26/2014
Galectin Therapeutics Secures U.S. Patent For Its Proprietary Galectin Inhibitor GR-MD-02 In Fatty Liver Disease 2/26/2014
IntelGenx Corp. Announces Receipt Of Two Additional U.S. Patent Allowances Related To Proprietary Technology 2/26/2014
Can-Fite BioPharma (CFBI) Granted Patent On The Manufacturing Of CF101 In Japan 2/25/2014
Mallinckrodt Pharmaceuticals (MNK) Receives Patent From U.S. Patent And Trademark Office 2/25/2014
ISA Pharmaceuticals Strengthens Patent Protection For Its Lead Product ISA101 2/24/2014
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Israeli Patent For Treatment Of Dry Eye Syndrome 2/24/2014
Rockwell Medical (RMTI) Receives Japanese Patent Issuance For Triferic™ GMP Formulation 2/21/2014
La Jolla Pharmaceutical Company (LJPC) Receives Notice Of Allowance For Patent Claims Covering Modified Pectin For Treatment Of Chronic Inflammation 2/20/2014
Mapi Pharma Granted United States Patent Covering The Process For The Preparation Of Fingolimod For Multiple Sclerosis 2/18/2014
BioAlliance Pharma: Strengthening And Extension Of The Industrial Protection Of Livatag® Until 2031 2/18/2014
Pluristem Therapeutics (PSTI) Receives Key 3D Cell Expansion Patent In Australia 2/18/2014



//-->